Japan approves Insmed's Brinsupri for lung disease treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. ACN
4. IONS
5. AZN
6. ROIV
7. AAPL
8. HOOD
9. QCOM
10. NVDA

Go back to Japan approves Insmed's Brinsupri for lung disease treatment
INSMED (NASDAQ: INSM) Delayed: 125.29 -1 (0.79%)
Previous Close $126.29    52 Week High $19.30 
Open $124.78    52 Week Low $9.02 
Day High $127.42    P/E N/A 
Day Low $121.38    EPS $-1.69 
Volume 579,723